The drug, which is prescribed to around 90% of people in the UK using weight-loss injections, will see the cost of its ...

The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' cheaper generic version of Novo Nordisk's older weight-loss drug, Saxenda, the Israel-based company said on Thursday.

The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' cheaper generic version of Novo Nordisk's older weight-loss drug, Saxenda, the Israel-based company said on Thursday.

Cigna’s Evernorth Health Services is investing $3.5 billion in Shield Health Solutions, a specialty pharmacy owned by the private equity firm that took over Walgreens.